Tsvee Lapidot
10Patents
6h-index
12Co-inventors
63Inventor score
Filing activity: Nov 22, 1991 → Oct 11, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6353150B1 | Chimeric mammals with human hematopoietic cells | Human Necessities | 55 | Expired |
| US8029780B2 | Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same | Chemistry; Metallurgy | 18 | Expired |
| US8367057B2 | Stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them | Chemistry; Metallurgy | 17 | Active |
| US8241903B2 | Catecholamine receptor modulation | Chemistry; Metallurgy | 15 | Active |
| US7101708B1 | Hematopoietic cell composition for use in transplantation | Chemistry; Metallurgy | 11 | Expired |
| US7198781B1 | Chimeric interleukin-6 soluble receptor/ligand proteins | Chemistry; Metallurgy | 7 | Expired |
| US7374912B2 | Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8252588B2 | Stem cells having increased sensitivity to SDF-1 and methods of generating and using same | Chemistry; Metallurgy | 0 | Active |
| US9155780B2 | Short beta-defensin-derived peptides | Human Necessities | 0 | Active |
| US9567371B2 | Short beta-defensin-derived peptides | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.